My Glioblastoma came back — what are my options now

I'm sorry to hear your glioblastoma has recurred. This is a challenging situation, and I want to help you understand what options exist and what questions to ask your care team.

Understanding Recurrent Glioblastoma

When glioblastoma returns after initial treatment, it means the cancer cells have regrown despite surgery, radiation, and/or chemotherapy. This is unfortunately common with glioblastoma, but there are several treatment approaches available today that didn't exist even a few years ago.

Treatment Approaches That Exist

1. Standard Chemotherapy Options Temozolomide (Temodar) remains a standard option for recurrent disease. Your oncologist may use it alone or in combination with other approaches.

2. Tumor Treating Fields (Optune) This FDA-approved device uses electrical fields to disrupt cancer cell division. According to the CancerPatientLab webinar on glioblastoma treatment, Optune can be combined with other therapies to potentially improve outcomes.

3. Immunotherapy Approaches This is an emerging area showing promise. Rather than poisoning cancer cells directly, immunotherapies work by reactivating your own immune system to recognize and attack the cancer.

One innovative approach being studied is personalized T-cell therapy (TVAX approach). According to Dr. [removed] Carter's research presented in the CancerPatientLab webinar "A Unique Personalized Killer T-cell Treatment for Glioblastoma," this approach:

• Uses your own tumor cells to create a personalized vaccine
• Collects your T cells (immune cells) via leukapheresis (a blood draw that separates out T cells)
• Activates and expands those T cells in the laboratory
• Returns approximately 50 billion activated T cells to your body
• Follows up with low-dose IL-2 injections to support continued T cell activity
• Has a "vein-to-vein" timeline of about 7 days, meaning the process from blood draw to reinfusion is relatively quick

The advantage of this approach is that it uses your own cells (not genetically modified), which means very few side effects compared to other immunotherapies.

4. Combination Approaches Dr. [removed] emphasizes that "combination therapy always tends to work better" than single treatments. This might mean combining immunotherapy with Optune, checkpoint inhibitors, or other approaches.

5. Clinical Trials There are multiple clinical trials for recurrent glioblastoma. The CancerPatientLab platform and resources can help connect you with trials you may be eligible for.

Important Considerations for Your Situation

According to the research, patients with a healthy immune system and minimal residual disease (small amount of remaining cancer) tend to respond best to immunotherapy approaches. Your oncologist will evaluate:

• Your overall health and immune function
• The extent of recurrence
• Your lymphocyte count (white blood cells important for immunity)
• Whether you've had prior treatments and how you tolerated them

Questions to Ask Your Oncology Team

1. What is the extent of my recurrence? (How much cancer has returned and where?)

2. Am I a candidate for immunotherapy approaches, including personalized T-cell therapy or checkpoint inhibitors?

3. What clinical trials am I eligible for? (Ask specifically about trials combining different approaches)

4. Should we consider Optune, and if so, could it be combined with other treatments?

5. What is my lymphocyte count, and does it meet criteria for T-cell based immunotherapy? (Generally, doctors want to see at least 800 lymphocytes)

6. What are the realistic goals of treatment? (Extending survival, improving quality of life, or both?)

7. Are there any off-label treatment options you'd recommend we discuss?

8. What is the timeline for starting treatment, and why?

Resources for Finding Clinical Trials

The CancerPatientLab webinars mention that platforms like Medoh are being developed specifically to help glioblastoma patients navigate and connect with appropriate clinical trials and treatment options. Ask your care team about clinical trial matching services.

A Note on Hope

While recurrent glioblastoma is serious, the landscape of treatment options has expanded significantly. Immunotherapy approaches, in particular, represent a fundamentally different way of fighting cancer—using your own immune system rather than just chemotherapy. Early research shows promise, and combination approaches are being actively studied.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.